Effect of Home Exercise Activity on Cortisol and Depression in COPD During the Pandemic COVID

Chronic Obstructive Pulmonary Disease Clinical Trial

Official title:

Effect of Home Exercise Activity on Cortisol and Depression in COPD Patients During the Pandemic COVID-19

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04639349
• Other study ID #: P.T.REC/012/002897
• Status: Recruiting
• Phase: N/A
• Start date: November 19, 2020
• Est. completion date: March 1, 2021

Study information

• Verified date: November 2020
• Source: Cairo University
• Contact: Ali Ismail, lecturer
• Phone: 02 01005154209
• Email: allooka2012[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

exercise activity during the COVID pandemic is appreciated to be conducted in home especially for chronic chest diseases as chronic obstructive pulmonary disease (COPD) to reduce the chance of viral contamination during the COVID-19 pandemic.

Description:

40 COPD men will be divided to exercise group (20 patients) and control group (20 patients):

the exercise group will receive a exercise session contains a fifty minutes exercise training at home with moderate intensity on the available training devices as bicycle or treadmill in addition to 30 minutes of exercising of upper and lower limb, the session will be repeated three times per week for eight weeks.

The control group will not be trained

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 40
• Est. completion date: March 1, 2021
• Est. primary completion date: March 1, 2021
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 50 Years to 70 Years

Eligibility

Inclusion Criteria:

• stable COPD patients

• patients who will have a training device as bicycle or treadmill in home

Exclusion Criteria:

• diabetic patients

• renal patients.

• liver diseases

Related Conditions & MeSH terms

• Chronic Obstructive Pulmonary Disease
• Lung Diseases, Obstructive
• Pulmonary Disease, Chronic Obstructive

Intervention

Behavioral:
• exercise group
the exercise group (20 patients) will receive a exercise session contains a fifty minutes exercise training at home with moderate intensity on the available training devices as bicycle or treadmill in addition to 30 minutes of exercising of upper and lower limb, the session will be repeated three times per week for eight weeks.

Other:
• control group
the control group will not be trained

Locations

Country	Name	City	State
Egypt	Faculty of Physical Therapy Cairo University	Giza	Dokki

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	cortisol	it will be measured in plasma	It will be measured after eight weeks of training
Primary	hospital anxiety and depression scale	this a questionnaire that will assess anxiety and depression in COPD patients	It will be measured after eight weeks of training
Secondary	pulmonary function test	it will be a measurement for lung volume and capacities	It will be measured after eight weeks of training
Secondary	Interleukin-8	It is an inflammatory marker in plasma	It will be measured after eight weeks of training
Secondary	body mass index	it will measure body mass changes	It will be measured after eight weeks of training
Secondary	six minute walking test	it assess functional capacity	It will be measured after eight weeks of training
Secondary	St. George's respiratory questionnaire	It assess the effect of COPD on general quality of life	It will be measured after eight weeks of training